Verastem, Inc. (VSTM)
5.72
0.00 (0.00%)
USD |
NASDAQ |
Feb 27, 16:00
5.72
0.00 (0.00%)
After-Hours: 20:00
Verastem Research and Development Expense (TTM) : 103.74M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amgen, Inc. | 7.281B |
| ADMA Biologics, Inc. | 4.761M |
| Zevra Therapeutics, Inc. | 16.83M |
| Immuneering Corp. | 47.41M |
| Tango Therapeutics, Inc. | 132.82M |